A detailed history of Janus Henderson Group PLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 45,700 shares of VKTX stock, worth $3.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,700
Previous 41,163 11.02%
Holding current value
$3.13 Million
Previous $3.38 Million 28.24%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $215,008 - $363,867
4,537 Added 11.02%
45,700 $2.42 Million
Q4 2023

Feb 14, 2024

SELL
$9.24 - $19.64 $739 - $1,571
-80 Reduced 0.19%
41,163 $766,000
Q3 2023

Nov 14, 2023

BUY
$10.92 - $16.0 $152 - $224
14 Added 0.03%
41,243 $456,000
Q2 2023

Aug 14, 2023

SELL
$14.84 - $24.79 $5.19 Million - $8.67 Million
-349,907 Reduced 89.46%
41,229 $668,000
Q1 2023

May 15, 2023

BUY
$8.08 - $17.33 $3.16 Million - $6.78 Million
391,136 New
391,136 $6.51 Million
Q2 2022

Aug 15, 2022

SELL
$2.11 - $3.15 $28,292 - $42,238
-13,409 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$4.6 - $6.72 $61,681 - $90,108
13,409 New
13,409 $62,000
Q4 2018

Feb 06, 2019

SELL
$7.16 - $16.21 $6.38 Million - $14.5 Million
-891,442 Closed
0 $0
Q3 2018

Nov 09, 2018

SELL
$9.7 - $19.65 $11.3 Million - $23 Million
-1,168,844 Reduced 56.73%
891,442 $15.5 Million
Q2 2018

Aug 10, 2018

BUY
$3.88 - $12.74 $7.99 Million - $26.2 Million
2,060,286 New
2,060,286 $19.6 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.25B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.